Sen-Hao Xiao

441 total citations
14 papers, 298 citations indexed

About

Sen-Hao Xiao is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Sen-Hao Xiao has authored 14 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 3 papers in Hematology and 2 papers in Cancer Research. Recurrent topics in Sen-Hao Xiao's work include Protein Degradation and Inhibitors (7 papers), Ubiquitin and proteasome pathways (4 papers) and Epigenetics and DNA Methylation (4 papers). Sen-Hao Xiao is often cited by papers focused on Protein Degradation and Inhibitors (7 papers), Ubiquitin and proteasome pathways (4 papers) and Epigenetics and DNA Methylation (4 papers). Sen-Hao Xiao collaborates with scholars based in China, Hong Kong and United States. Sen-Hao Xiao's co-authors include Cheng Luo, Shijie Chen, Bing Zhou, Yaxi Yang, Feng Yang, Xin Zhang, Wei‐Fen Xie, Shuqing Liu, Qin-Juan Sun and Chen‐Hong Ding and has published in prestigious journals such as Nucleic Acids Research, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Sen-Hao Xiao

14 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sen-Hao Xiao China	12	234	65	47	35	24	14	298
Daniel D. Waller Canada	8	209 0.9×	41 0.6×	39 0.8×	63 1.8×	19 0.8×	14	280
Savita Lochab India	11	242 1.0×	48 0.7×	42 0.9×	58 1.7×	58 2.4×	26	362
Hua Yan China	9	165 0.7×	29 0.4×	70 1.5×	46 1.3×	11 0.5×	22	251
Sang Wu Lee South Korea	11	329 1.4×	97 1.5×	19 0.4×	90 2.6×	23 1.0×	14	405
Kaoru Mitsuhashi Japan	4	314 1.3×	36 0.6×	36 0.8×	93 2.7×	49 2.0×	7	389
Lipeng Dai United States	7	227 1.0×	56 0.9×	55 1.2×	116 3.3×	41 1.7×	8	329
Viacheslav V. Senichkin Sweden	8	241 1.0×	48 0.7×	24 0.5×	93 2.7×	20 0.8×	13	302
Yu Jia United States	8	259 1.1×	36 0.6×	76 1.6×	44 1.3×	14 0.6×	14	373
Daniel J. Termine United States	6	118 0.5×	70 1.1×	19 0.4×	44 1.3×	11 0.5×	6	236
Kazushi Araki Japan	12	264 1.1×	42 0.6×	57 1.2×	49 1.4×	25 1.0×	24	379

Countries citing papers authored by Sen-Hao Xiao

Since Specialization

Citations

This map shows the geographic impact of Sen-Hao Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sen-Hao Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sen-Hao Xiao more than expected).

Fields of papers citing papers by Sen-Hao Xiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sen-Hao Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sen-Hao Xiao. The network helps show where Sen-Hao Xiao may publish in the future.

Co-authorship network of co-authors of Sen-Hao Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Sen-Hao Xiao. A scholar is included among the top collaborators of Sen-Hao Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sen-Hao Xiao. Sen-Hao Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Guo, Siqi, Xiao‐Ming Xu, Feng Yang, et al.. (2023). Design, synthesis of novel benzimidazole derivatives as ENL inhibitors suppressing leukemia cells viability via downregulating the expression of MYC. European Journal of Medicinal Chemistry. 248. 115093–115093. 9 indexed citations

Liao, Liping, Wenzhen Dang, Tingting Lin, et al.. (2022). A potent PGK1 antagonist reveals PGK1 regulates the production of IL-1β and IL-6. Acta Pharmaceutica Sinica B. 12(11). 4180–4192. 26 indexed citations

Wang, Kai, Bei Zhang, Siqi Guo, et al.. (2022). Design, synthesis, and biological evaluation of novel carbazole derivatives as potent DNMT1 inhibitors with reasonable PK properties. Journal of Enzyme Inhibition and Medicinal Chemistry. 37(1). 1537–1555. 6 indexed citations

Lu, Tian, Haibo Lu, Z. H. Duan, et al.. (2021). Discovery of High-Affinity Inhibitors of the BPTF Bromodomain. Journal of Medicinal Chemistry. 64(16). 12075–12088. 12 indexed citations

Li, Wen, Liping Liao, Ning Song, et al.. (2021). Natural product 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose is a reversible inhibitor of glyceraldehyde 3-phosphate dehydrogenase. Acta Pharmacologica Sinica. 43(2). 470–482. 16 indexed citations

Sun, Yanli, Haibo Lu, Sen-Hao Xiao, et al.. (2021). Discovery of a novel 53BP1 inhibitor through AlphaScreen-based high-throughput screening. Bioorganic & Medicinal Chemistry. 34. 116054–116054. 11 indexed citations

Xiao, Sen-Hao, Siqi Guo, Jie Han, et al.. (2021). High-Throughput-Methyl-Reading (HTMR) assay: a solution based on nucleotide methyl-binding proteins enables large-scale screening for DNA/RNA methyltransferases and demethylases. Nucleic Acids Research. 50(2). e9–e9. 13 indexed citations

Chen, Shijie, Sen-Hao Xiao, Qin-Juan Sun, et al.. (2020). Targeting p300/CBP Attenuates Hepatocellular Carcinoma Progression through Epigenetic Regulation of Metabolism. Cancer Research. 81(4). 860–872. 105 indexed citations

Xiao, Sen-Hao, Yaxi Yang, Chao Chen, et al.. (2020). Discovery of 8-Methyl-pyrrolo[1,2-a]pyrazin-1(2H)-one Derivatives as Highly Potent and Selective Bromodomain and Extra-Terminal (BET) Bromodomain Inhibitors. Journal of Medicinal Chemistry. 63(8). 3956–3975. 23 indexed citations

10.

Liao, Liping, Yu Zuo, Dan Zhang, et al.. (2019). Discovery of novel CBP bromodomain inhibitors through TR-FRET-based high-throughput screening. Acta Pharmacologica Sinica. 41(2). 286–292. 13 indexed citations

11.

Zhang, Dan, Jie Han, Wenchao Lu, et al.. (2019). Discovery of alkoxy benzamide derivatives as novel BPTF bromodomain inhibitors via structure-based virtual screening. Bioorganic Chemistry. 86. 494–500. 13 indexed citations

12.

Xiao, Sen-Hao, Yantao Chen, Hao Jiang, et al.. (2018). Design, synthesis and biological evaluation of benzo[cd]indol-2(1H)-ones derivatives as BRD4 inhibitors. European Journal of Medicinal Chemistry. 152. 264–273. 23 indexed citations

13.

Li, Zhang, Yantao Chen, Na Liu, et al.. (2018). Design, synthesis and anti leukemia cells proliferation activities of pyrimidylaminoquinoline derivatives as DOT1L inhibitors. Bioorganic Chemistry. 80. 649–654. 15 indexed citations

14.

Li, Linjuan, Yantao Chen, Jingqiu Liu, et al.. (2018). Discovery of potent DOT1L inhibitors by AlphaLISA based High Throughput Screening assay. Bioorganic & Medicinal Chemistry. 26(8). 1751–1758. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact